These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Tuberculostatics. General adverse effects]. Mordasini ER; Eulenberger J Int Z Klin Pharmakol Ther Toxikol; 1972 Feb; 5(4):499-518. PubMed ID: 4339952 [No Abstract] [Full Text] [Related]
3. Treatment of tuberculosis today in Nebraska. Burgher LW; Kass I Nebr Med J; 1973 May; 58(5):156-62. PubMed ID: 4348990 [No Abstract] [Full Text] [Related]
4. Drugs for tuberculosis. Br Med J; 1968 Sep; 3(5619):664-7. PubMed ID: 4175142 [No Abstract] [Full Text] [Related]
5. The treatment of drug resistant chronic pulmonary tuberculosis with new tuberculostatics. Zierski M Bull Int Union Tuberc; 1968 Dec; 41():194-200. PubMed ID: 4303863 [No Abstract] [Full Text] [Related]
6. [Some chemotherapeutic agents used infrequently in the treatment of human pulmonary tuberculosis: viomycin, oxytetracycline, neomycin, framycetin]. SEREMBE M Clin Ter; 1958 Apr; 14(4):393-431. PubMed ID: 13547447 [No Abstract] [Full Text] [Related]
7. Side effects of drugs used to treat tuberculosis. Newton RW Scott Med J; 1975 Mar; 20(2):47-9. PubMed ID: 47648 [No Abstract] [Full Text] [Related]
8. [The treatment of urogenital tuberculosis with current drugs]. König K; May P Urologe; 1968; 7(1):23-9. PubMed ID: 4297580 [No Abstract] [Full Text] [Related]
9. [Chemotherapeutic activity and diffusion properties of the second series antituberculous preparations]. Drabkina RO; Ginzburg TS Klin Med (Mosk); 1966 Dec; 44(12):38-43. PubMed ID: 4302345 [No Abstract] [Full Text] [Related]
10. [Tuberculostatics of the second order (relay drugs). Their share in combined therapy of pulmonary tuberculosis]. Naegeli HR Schweiz Med Wochenschr; 1966 Apr; 96(15):495-500. PubMed ID: 4293638 [No Abstract] [Full Text] [Related]
11. [Comparative study on regimen using tuberactinomycin-N intermittent and daily and viomycin intermittent in combination with rifampicin. The 15th Series-A Study]. Kekkaku; 1973 Apr; 48(4):129-34. PubMed ID: 4124626 [No Abstract] [Full Text] [Related]
12. [Allergy to antitubercular agents; with special reference to new drugs]. Mühlberger F Schweiz Med Wochenschr; 1973 Jan; 103(4):126-31. PubMed ID: 4119096 [No Abstract] [Full Text] [Related]
13. Capreomycin and other drugs in the treatment of pulmonary tuberculosis. Zierski M Tubercle; 1969 Mar; 50():Suppl:37-9. PubMed ID: 4319132 [No Abstract] [Full Text] [Related]
14. [Experience in treatment of patients with chronic destructive pulmonary tuberculosis in a suburban tuberculosis hospital]. Sirota DS; Man'kovetskiĭ EF; Koĭfman SG; Vatsyk MZ Probl Tuberk; 1974; (10):17-9. PubMed ID: 4370967 [No Abstract] [Full Text] [Related]
15. [Tuberculostatic tolerance of a tuberculous kidney]. Strauss I Z Urol Nephrol; 1969; 62(9):651-6. PubMed ID: 4325816 [No Abstract] [Full Text] [Related]
17. [Internal medicine treatment of pulmonary tuberculosis]. Schaich W Med Klin; 1970 Sep; 65(36):1553-8. PubMed ID: 4995072 [No Abstract] [Full Text] [Related]
18. [Clinical studies of cochleotoxicosis due to viomycin and kanamycin during tuberculostatic treatment (a prophylactic attempt)]. Erlach A Monatsschr Ohrenheilkd Laryngorhinol; 1968; 102(11):624-30. PubMed ID: 4302952 [No Abstract] [Full Text] [Related]
19. [Advances and principles in tuberculostatic therapy]. Bethge H Internist (Berl); 1971 Aug; 12(8):328-31. PubMed ID: 4328130 [No Abstract] [Full Text] [Related]